If the pursuit of a COVID-19 vaccine were a horse race, a company in San Diego is either the Seabiscuit or darkhorse candidate to win. With a newly acquired $173 million dollars from Wall Street after a public stock offering, Arcturus Therapeutics Holdings Inc. just gained some solid footing in the race....